GHAFIR EL IDRISSI, IMANE
 Distribuzione geografica
Continente #
NA - Nord America 384
EU - Europa 134
AS - Asia 79
Totale 597
Nazione #
US - Stati Uniti d'America 383
IT - Italia 52
CN - Cina 40
SE - Svezia 33
SG - Singapore 32
DE - Germania 10
GB - Regno Unito 9
FR - Francia 8
FI - Finlandia 6
BE - Belgio 3
IN - India 3
UA - Ucraina 3
ES - Italia 2
PL - Polonia 2
RU - Federazione Russa 2
CA - Canada 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
IE - Irlanda 1
JP - Giappone 1
KG - Kirghizistan 1
KR - Corea 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
Totale 597
Città #
Fairfield 60
Chandler 40
Woodbridge 35
Ann Arbor 34
Bari 33
Singapore 29
Houston 26
Nyköping 26
Ashburn 20
Wilmington 19
Boardman 17
Cambridge 16
Seattle 16
Jacksonville 9
Unterföhring 8
Lawrence 7
Nanjing 7
Beijing 6
Des Moines 6
Roxbury 6
Princeton 5
Rome 4
Brooklyn 3
Brussels 3
Dearborn 3
Guangzhou 3
Helsinki 3
Wuxi 3
Corigliano Calabro 2
Ferrara 2
Jiaxing 2
Krakow 2
London 2
Madrid 2
Marseille 2
New York 2
Paris 2
Patna 2
West Jordan 2
Wuhan 2
Bishkek 1
Brno 1
Catanzaro 1
Chongqing 1
Dublin 1
Giugliano in Campania 1
Glasgow 1
Hebei 1
Heze 1
Hounslow 1
Inglewood 1
Jinan 1
Jinhua 1
Los Angeles 1
Norwalk 1
Pune 1
Quanzhou 1
Redwood City 1
San Diego 1
Shanghai 1
Strasbourg 1
Tokyo 1
Toronto 1
Turi 1
Zurich 1
Totale 496
Nome #
miRNAs for the Detection of MultiDrug Resistance: Overview and Perspectives 152
P-GP RADIOTRACER FOR IMAGING AS BIOMARKERS INVOLVED IN ONSET OF NEURODEGENERATIVE DISEASE 109
Non-ceruplasmin copper didtincts subtypes in Alzheimer's disease: a genetic study of ATP7B frequency 74
Measurements of serum non-ceruloplasmin copper by a direct fluorescent methodspecific to Cu(II) 72
Miscele di caffè per la neuroprotezione 42
Amyloid binding and beyond: a new approach for Alzheimer's disease drug discovery targeting Abo–PrPC binding and downstream pathways 40
Glucosylpolyphenols as Inhibitors of Aβ-Induced Fyn Kinase Activation and Tau Phosphorylation: Synthesis, Membrane Permeability, and Exploratory Target Assessment within the Scope of Type 2 Diabetes and Alzheimer's Disease 38
COLD KITS BASED ON PSMA LIGANDS FOR THE PREPARATION OF RADIOPHARMACEUTICALS 27
Liquid Biopsy beyond Cancer: A miRNA Detection in Serum with Electrochemical Chip for Non‐Invasive Coeliac Disease Diagnosis 20
Structure-Activity Relationships and Therapeutic Potential of Purinergic P2X7 Receptor Antagonists 18
RATIONAL DESIGN AND SYNTHESIS OF POTENTIAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) RADIOLIGANDS FOR IN VIVO IMAGING OF P2X7 RECEPTORS 11
Microglia Depletion Attenuates the Pro-Resolving Activity of the Formyl Peptide Receptor 2 Agonist AMS21 Related to Inhibition of Inflammasome NLRP3 Signalling Pathway: A Study of Organotypic Hippocampal Cultures 10
A novel cell-based assay to screen compounds which disrupts PrPC-Aβ1-42 oligomers interaction 9
Discovery of N-methylpiperazinyl flavones as a novel class of compounds with therapeutic potential against Alzheimer’s disease: synthesis, binding affinity towards amyloid β oligomers (Aβo) and ability to disrupt Aβo-PrPC interactions. 8
Discovery of N-methylpiperazinyl flavones as a novel class of compounds with therapeutic potential against Alzheimer’s disease: synthesis, binding affinity towards amyloid β oligomers (Aβo) and ability to disrupt Aβo-PrPC interactions 6
Drug Discovery for Alzheimer’s Disease: Screen of small molecules able to inhibit PrPC-Abos interaction using ICC and the role of Cu2+ in this scenarios. 6
Early Diagnosis of Alzheimer’s Disease by a Synergistic Evaluation of Free Copper Ion in the Serum and SPECT Analysis 5
Multitarget-Directed Ligands Hitting Serotonin Receptors: A Medicinal Chemistry Survey 5
Totale 652
Categoria #
all - tutte 3.177
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.177


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202051 0 0 0 0 0 8 8 8 8 9 6 4
2020/2021114 6 4 1 24 5 0 8 17 9 16 13 11
2021/202267 9 8 2 1 1 7 2 2 3 6 10 16
2022/2023109 16 16 10 8 12 8 2 14 14 0 4 5
2023/202493 2 6 2 12 5 3 7 1 14 5 17 19
2024/2025102 31 6 17 12 22 14 0 0 0 0 0 0
Totale 652